A Novel MYH9-RET Fusion Occurrence and EGFR T790M Loss as an Acquired Resistance Mechanism to Osimertinib in a Patient with Lung Adenocarcinoma: A Case Report
Yanwei Sun,1 Lina Pei,2 Ningning Luo,3 Dongsheng Chen,3 Lingxin Meng1 1Department of Oncology, People’s Hospital of Rizhao, Rizhao, People’s Republic of China; 2Department of Pharmacy, People’s Hospital of Rizhao, Rizhao, People’s Republic of China; 3The State...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-11-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/a-novel-myh9-ret-fusion-occurrence-and-egfr-t790m-loss-as-an-acquired--peer-reviewed-article-OTT |